An investigation of the MEK/ERK inhibitor U0126 in acute myeloid leukemia.

An investigation of the MEK/ERK inhibitor U0126 in acute myeloid leukemia.

Item
http://www.wikidata.org/entity/Q40576322
PI3K-AKT-mTOR-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasmsBlockade of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase and murine double minute synergistically induces Apoptosis in acute myeloid leukemia via BH3-only proteins Puma and Bim.U0126 protects cells against oxidative stress independent of its function as a MEK inhibitor.c-Jun N-terminal kinase (JNK) is required for survival and proliferation of B-lymphoma cellsOvercoming resistance to molecularly targeted anticancer therapies: Rational drug combinations based on EGFR and MAPK inhibition for solid tumours and haematologic malignanciesTetraspanin CD82 Regulates the Spatiotemporal Dynamics of PKCα in Acute Myeloid LeukemiaBeyond DNA Repair: Additional Functions of PARP-1 in Cancer.MAPK signaling pathways in the regulation of hematopoiesis.The heterogeneity of pediatric MLL-rearranged acute myeloid leukemia.Identification of new possible targets for leukemia treatment by kinase activity profiling.
P2860

An investigation of the MEK/ERK inhibitor U0126 in acute myeloid leukemia.

Item
http://www.wikidata.org/entity/Q40576322
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
An investigation of the MEK/ERK inhibitor U0126 in acute myeloid leukemia.
@en
type
label
An investigation of the MEK/ERK inhibitor U0126 in acute myeloid leukemia.
@en
prefLabel
An investigation of the MEK/ERK inhibitor U0126 in acute myeloid leukemia.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P478
P577
P698
P921
P356
P1433
P1476
An investigation of the MEK/ERK inhibitor U0126 in acute myeloid leukemia.
@en
P2093
P2860
P304
P31
P356
P407
P478
P577
P698
P921